US Patent Issued to OSAKA UNIVERSITY on March 25 for "Method for predicting effect of tumor immunotherapy using tumor cytotoxic activity of peripheral blood T cells as index" (Japanese Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,259,379, issued on March 25, was assigned to OSAKA UNIVERSITY (Suita, Japan).

"Method for predicting effect of tumor immunotherapy using tumor cytotoxic activity of peripheral blood T cells as index" was invented by Kota Iwahori (Suita, Japan) and Hisashi Wada (Suita, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "An object of the present invention is to provide a companion diagnostic for predicting the effect of a tumor immunotherapy. The effect of a tumor immunotherapy is predicted by a method including step 1: contacting directly or indirectly peripheral blood mononuclear cells collected from a patient who is a target for treatment of a malign...